Active Ingredient: NILUTAMIDE
Proprietary Name: NILANDRON
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020169
Product Number: 002
Approval Date: Apr 30, 1999
Applicant Holder Full Name: CONCORDIA PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information